Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation

Experimental and Molecular Pathology

Volumn 84, Issue 2, 2008, Pages 141-144

  McCourtie, Anton S ^a   Farivar, Alexander S ^a   Woolley, Steven M ^a   Merry, Heather E ^a   Wolf, Patrick S ^a   Szabo, Csaba ^b   Mulligan, Michael S ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b INOTEK CORPORATION   (United States)

Author keywords

Alveolar macrophage; Chemokines; Hypoxia; In vitro; Lung ischemia reperfusion injury cytokines; PARS; Reoxygenation

Indexed keywords

CHEMOKINE; CYTOKINE; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INO 1001; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPOXIA; INCUBATION TIME; LUNG ALVEOLUS MACROPHAGE; MALE; NONHUMAN; PROTEIN SECRETION; RAT; REOXYGENATION;

ANIMALS; ANOXIA; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINES; ENZYME INHIBITORS; INDOLES; MACROPHAGES, ALVEOLAR; MALE; NF-KAPPA B; OXIDATIVE STRESS; OXYGEN; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, LONG-EVANS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 40949116390     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2007.11.005     Document Type: Article

References (19)

1. Abdelkarim G.E., Gertz K., Harms C., Katchanov J., Dirnagl U., Szabo C., and Endres M. Protective effects of PJ34, a novel, potent inhibitor of poly (ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int. J. Mol. Med. 7 3 (2001) 255-260 Mar
2. Farivar A.S., Woolley S.M., Naidu B.V., Fraga C.H., Byrne K., Thomas R., Salzman A.L., Szabo C.S., and Mulligan M.S. Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts. J. Heart Lung Transplant. 23 8 (2004) 993-1002 (Aug)
3. Farivar A.S., Woolley S.M., Fraga C.H., Byrne K., and Mulligan M.S. Proinflammatory response of alveolar type II pneumocytes to in vitro hypoxia and reoxygenation. Am. J. Transplant. 4 3 (2004) 346-351 (Mar)
4. Fiser S.M., Tribble C.G., Long S.M., Kaza A.K., Kern J.A., and Kron I.L. Pulmonary macrophages are involved in reperfusion injury after lung transplantation. Ann. Thorac. Surg. 71 4 (2001) 1134-1138 (Apr) discussion 1138-1139
5. Hassa P.O., Covic M., Hasan S., Imhof R., and Hottiger M.O. The enzymatic and DNA binding activity of PARP-1 are not required for NF-kappa B coactivator function. J. Biol. Chem. 276 49 (2001) 45588-45597 (Dec 7)
6. Jagtap P., Soriano F.G., Virag L., Liaudet L., Mabley J., Szabo E., Hasko G., Marton A., Lorigados C.B., Gallyas Jr. F., Sumegi B., Hoyt D.G., Baloglu E., VanDuzer J., Salzman A.L., Southan G.J., and Szabo C. Novel phenanthridinone inhibitors of poly (adenosine 5′-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents. Crit. Care Med. 30 5 (2002) 1071-1082 (May)
7. Liaudet L., Soriano F.G., Szabo E., Virag L., Mabley J.G., Salzman A.L., and Szabo C. Protection against hemorrhagic shock in mice genetically deficient in poly (ADP-ribose) polymerase. Proc. Natl. Acad. Sci. U. S. A. 97 18 (2000) 10203-10208 (Aug 29)
8. Liaudet L., Szabo E., Timashpolsky L., Virag L., Cziraki A., and Szabo C. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br. J. Pharmacol. 133 8 (2001) 1424-1430 (Aug)
9. Mabley J.G., Jagtap P., Perretti M., Getting S.J., Salzman A.L., Virag L., Szabo E., Soriano F.G., Liaudet L., Abdelkarim G.E., Hasko G., Marton A., Southan G.J., and Szabo C. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm. Res. 50 11 (2001) 561-569 (Nov)
10. Martin D.R., Lewington A.J., Hammerman M.R., and Padanilam B.J. Inhibition of poly (ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am. J. Physiol., Regul. Integr. Comp. Physiol. 279 5 (2000) R1834-R1840 (Nov)
11. Naidu B.V., Krishnadasan B., Farivar A.S., Woolley S.M., Thomas R., Van Rooijen N., Verrier E.D., and Mulligan M.S. Early activation of the alveolar macrophage is critical to the development of lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 126 1 (2003) 200-207 (Jul)
12. Naidu B.V., Woolley S.M., Farivar A.S., Thomas R., Fraga C.H., Goss C.H., and Mulligan M.S. Early tumor necrosis factor-alpha release from the pulmonary macrophage in lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 127 5 (2004) 1502-1508 (May)
13. Naidu B.V., Krishnadasan B., Byrne K., Farr A.L., Rosengart M., Verrier E.D., and Mulligan M.S. Regulation of chemokine expression by cyclosporine A in alveolar macrophages exposed to hypoxia and reoxygenation. Ann. Thorac. Surg. 74 3 (2002) 899-905 (Sep) discussion 905
14. Oliver F.J., Menissier-de Murcia J., Nacci C., Decker P., Andriantsitohaina R., Muller S., de la Rubia G., Stoclet J.C., and de Murcia G. Resistance to endotoxic shock as a consequence of defective NF-kappa B activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J. 18 16 (1999) 4446-4454 (Aug 16)
15. Soriano F.G., Liaudet L., Szabo E., Virag L., Mabley J.G., Pacher P., and Szabo C. Resistance to acute septic peritonitis in poly (ADP-ribose) polymerase-1-deficient mice. Shock 17 4 (2002) 286-292 (Apr)
16. Szabo C., and Dawson V.L. Role of poly (ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci. 19 7 (1998) 287-298 (Jul) Review
17. Szabo G., Bahrle S., Stumpf N., Sonnenberg K., Szabo E.E., Pacher P., Csont T., Schulz R., Dengler T.J., Liaudet L., Jagtap P.G., Southan G.J., Vahl C.F., Hagl S., and Szabo C. Poly (ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ. Res. 90 1 (2002) 100-106 (Jan 11)
18. Woolley S.M., Farivar A.S., Naidu B.V., Salzman A., Szabo C., Thomas R., Fraga C., and Mulligan M.S. Role of poly (ADP) ribose synthetase in lung ischemia-reperfusion injury. J. Heart Lung Transplant. 23 11 (2004) 1290-1296 (Nov)
19. Zingarelli B., Cuzzocrea S., Zsengeller Z., Salzman A.L., and Szabo C. Protection against myocardial ischemia and reperfusion injury by 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc. Res. 36 2 (1997) 205-215 (Nov)